Business Context and Reporting Period
Company: Bowhead Specialty Holdings Inc. (NYSE: BOW)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: Bowhead is a commercial specialty property and casualty (P&C) insurer focusing on casualty, professional liability, and healthcare liability risks. Founded in 2020, the company operates primarily on an excess and surplus (E&S) basis. It utilizes a strategic partnership with American Family Mutual Insurance Company (AmFam), issuing policies on AmFam paper through its managing general agency (BSUI) and reinsuring 100% of the risk to its insurance subsidiary (BICI). The company completed its Initial Public Offering (IPO) in May 2024.
Key Financial Metrics
| Metric ($ in thousands) | 2024 | 2023 | Change |
|---|---|---|---|
| Gross Written Premiums | $695,717 | $507,688 | +37.0% |
| Net Written Premiums | $451,422 | $334,672 | +34.9% |
| Net Earned Premiums | $385,111 | $263,902 | +45.9% |
| Net Investment Income | $40,121 | $19,371 | +107.1% |
| Net Income | $38,243 | $25,047 | +52.7% |
| Underwriting Income (Non-GAAP) | $18,236 | $14,035 | +29.9% |
| Combined Ratio | 95.8% | 94.9% | +0.9 pts |
| Loss Ratio | 64.4% | 63.0% | +1.4 pts |
| Expense Ratio | 31.4% | 31.9% | -0.5 pts |
| Total Assets | $1,654,242 | $1,027,859 | N/A |
| Stockholders' Equity | $370,177 | $192,077 | N/A |
Liquidity & Debt: As of December 31, 2024, the company held $97.5 million in cash and cash equivalents and $124.6 million in restricted cash. The company has a $75 million senior secured revolving credit facility with no outstanding borrowings as of year-end.
Material Changes vs. Prior Period
- Premium Growth: Gross written premiums increased 37.0% to $695.7 million, driven by renewals, new business, and the launch of the "Baleen Specialty" division in May 2024. The Casualty division was the primary growth driver, increasing 55.6%.
- Profitability: Net income rose 52.7% to $38.2 million. Underwriting income increased 29.9% to $18.2 million. The combined ratio improved slightly in terms of expense management but increased overall due to a higher loss ratio.
- Investment Income: Net investment income more than doubled (107.1%) to $40.1 million, attributed to a larger investment portfolio (fueled by IPO proceeds) and higher yields on fixed-income assets.
- Reserve Reallocation: In Q4 2024, the company reallocated prior accident year loss reserves from Professional Liability to Casualty to align with industry loss ratios. This contributed to the 1.4 point increase in the loss ratio.
- Capital Structure: Stockholders' equity increased by $178.4 million, primarily due to $131.0 million in net proceeds from the May 2024 IPO and $38.2 million in net income.
Guidance, Outlook, Risks, and Unusual Items
Outlook & Strategy: Management aims to maintain an "underwriting-first" culture, focusing on profitable growth across market cycles. The company plans to expand its "flow" underwriting operation (Baleen Specialty) and leverage its technology platform (BRATs) to drive efficiency. No specific numerical guidance for 2025 was provided in the text.
Unusual Items:
- IPO Costs: The company incurred $2.8 million in non-operating expenses related to the IPO and Secondary Offering, which reduced net income.
- Warrant Expense: $1.9 million in warrant expense was recognized related to warrants issued to AmFam.
Key Risks:
- AmFam Partnership: The business model relies heavily on the strategic relationship with AmFam. A termination of this relationship or a downgrade of AmFam's financial strength rating could materially adversely affect operations.
- Reserve Adequacy: Due to a limited operating history (founded 2020), the company relies on industry data for reserving. Actual losses could deviate significantly from estimates.
- Reinsurance Concentration: While reinsurers are highly rated (A or better), the company faces credit risk if reinsurers fail to reimburse claims. Top five reinsurers account for 91.3% of recoverables.
- Broker Concentration: 68.3% of gross written premiums in 2024 were distributed through just four brokers.
Investor Verification Checklist
- AmFam Dependency: Verify the terms and stability of the Managing General Agency (MGA) and Quota Share agreements with AmFam, as the company writes business on AmFam paper.
- Reserve Development: Monitor future loss development, particularly in the Casualty division where reserves were reallocated in 2024, given the company's short loss history.
- Broker Concentration: Assess the risk associated with 68.3% of premiums coming from four brokers and the potential impact of broker consolidation or attrition.
- Reinsurance Renewals: Track the renewal of reinsurance treaties (Cyber renews Jan 1, 2025; others May 1, 2025) for changes in pricing or terms.
- Capital Deployment: Observe how the company deploys the $131 million in IPO proceeds and whether it maintains its conservative investment strategy (AA-rated fixed income).